三阴性乳腺癌放射治疗的研究进展

doi:10.11904/j.issn.1002-3070.2016.02.019

Abstract

Abstract: The triple negative breast cancer is one of importance in clinical subtypes of breast cancer,which is easy to recur and metastasis,and its prognosis is very poor.Radiotherapy,as an effective method for breast cancer,can reduce the risk of local recurrence.This article elaborates its characteristics,the progress of radiotherapy in the breast conserving surgery and modified radical mastectomy in triple negative breast cancer,when is the appropriate time for radiotherapy and radiotherapy sensitization,and hope that it will be helpful to the treatments.

Key words: Triple negative breast cancer, Breast conserving surgery, Radiotherapy, Radiotherapy sensitization

CLC Number:

R737.9

LUO Hongyu, LI Jiaqi, LUAN Jinwei, ZHANG Siliang, LI Xianglan. The progress of radiotherapy in triple negative breast cancer[J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(2): 180-183.

References

1 Meena M.Radiation therapy in the locoregional treatment of triple-negative breast cancer[J].Lancet Oncol,2015,16(3):113-122.
2 Boyle P.Triple-negative breast cancer:epidemiological considerations and recommendations[J].Ann Oncol,2012,23(6):7-12.
3 Sioshansi S,Ehdaivand S,Cramer C,et al.Triple negative breast cancer is associated with an increased risk of residual invasive carcinoma after lumpectomy[J].Cancer,2012,118(16):3893-3898.
4 Part A,Adamo B,Cheang MC,et al.Molecular characterization of basal-like and non-basal-like triple-negative berast cancer[J].Oncologist,2013,18(2):123-133.
5 Lehmann BD,Bauer JA,Chen X,et al.Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies[J].J Clin Invest,2011,121(7):2750-2767.
6 Lehmann BD,Pietenpol JA.Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes[J].J Pathol,2014,232(2):142-150.
7 Lehmann BD,Bauer JA,Chen X,et al.Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies[J].J Clin Invest,2011,121(7):2750-2767.
8 Gazinska P,Grigoriadis A,Brown JP,et al.Comparison of basal-like triple-negative breast cancer defined by morphology,immunohistochemistry and transcriptional profiles[J].Mod Pathol,2013,26(7):955-966.
9 杜娟,阮祥燕.三阴乳腺癌的特点及研究进展[J].首都医科大学学报,2015,36(4):578-582.
10 Perou CM.Molecular stratification of triple-negative breast cancers[J].Oncologist,2010,15(5):39-48.
11 Kyndi M,Srensen FB,Knudsen H,et al.Estrogen receptor,progesterone receptor,HER-2,and response to postmastectomy radiotherapy in high-risk breast cancer:the Danish Breast Cancer Cooperative Group[J].Clin Oncol,2008,26(9):1419-1426.
12 Freedman GM,Anderson PR,Li T,et al.Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation[J].Cancer,2009,115(5):945-946.
13 Pignol JP,Rakovitch E,Olivotto IA.et al.Is breast conservation therapy superior mastectomy for women with triple-negative breast cancers?[J].Clin Oncol,2011,29(21):2841-2843.
14 Lauche O,Azria D,Riou O,et al.Radiosensitivity in breast cancer[J].Cancer Radiother,2015,19(4):237-240.
15 Haviland JS,Owen JR,Dewar JA,et al.The UK standardisation of breast radiotherapy(START)trials of radiotherapy hypofraction-ation for treatment of early breast cancer:10-year follow-up results of two randomised controlled trials[J].Lancet Oncol,2013,14(11):1086-1094.
16 王伟,王捷.乳腺癌不同放疗分割模式的研究进展[J].肿瘤预防与治疗,2015,28(3):174-178.
17 冶秀鹏,马小萍,包慎,等.早期乳腺癌保乳术后大分割放疗的Meta 分析[J].现代肿瘤医学,2015,23(16):2292-2230.
18 余子豪.乳腺癌放射治疗进展[J].中国实用外科杂志,2015,35(97):784-786.
19 Vesonesi U,Oreccchia R,Maisonneuve P,et al.Intraoperative radiotherapy versus external radiotherapy for early breast cancer(ELIOT):a randomised controlled equivalence trail[J].Lancet Oncol,2013,14(13):1269-1277.
20 Fastner G,Hauser-Kronberger C,Moder A.Survival and local control rates of triple-negative breast cancer patients treated with boost-IOERT during breast-conserving surgery[J].Stralenther Onkol,2016,192(1):1-7.
21 Vaidya JS,Wenz F,Bulsara M,et al.Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer:5-year results for local control and overall survival from the TARGIT-A randomised trail[J].Lancet,2014,383(9917):603-613.
22 Stull TS,Goodwin CM,Gracely EJ,et al.A single-institution review of accelerated partial breast irradiation in patients considered ‘cautionary’ by the American Society for Radiation Oncology[J].Ann Surg Oncol,2012,19(2):553-559.
23 Wilkinson JB,Reid RE,Shaitelman SF,et al.Outcomes of breast cancer patients with triple negative receptor status treated with accelerated partial breast iradiation[J].Radiat Oncol Biol Phys,2011,81(3):159-164.
24 Abi-Raad R,Boutrus R,Wang R,et al.Patterns and risk factors of locoregional recurrence in T1-T2 node negative breast cancer patients treated with mastectomy:implications for postmastectomy radiotherapy[J].Int J Radiat Oncol Biol Phys,2011,81(3):e151-e157.
25 Wang J,Shi M,Ling R,et al.Increased risk of locoregional recurrence for women with T_1-2N₀ triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy[J].Clin Oncol,2011,29(21):2852-2858.
26 Abdukarim BS,Cuartero J,Hanson J,et al.Increased risk of locoregional recurrence for women with T_1-2N₀ triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy[J].Clin Oncol,2011,29(21):2852-2858.
27 Rowell NP.Radiotherapy to the chest wall following mastectomy for node-negative breast cancer:a systematic review[J].Radiother Oncol,2009,91(1):23-32.
28 Hickey BE,Fmncis DP,Lehman M.Sequencing of chemotherapy and radiotherapy for early breast cancer[J].Cochrane Database Syst Rev,2013(4):323-331.
29 Buchholz TA,Austin-Seymour MM,Moe RE,et a1.Effect of delay in radiation in the combined modality treatment of breast cancer[J].Int Radiat Oncol Biol Phys,1993,26(1):23-35.
30 李冰馨,傅深.三阴性乳腺癌放射治疗相关机制的研究进展[J].中国癌症杂志,2014,24(11),865-870.
31 Hirai T,Shirai H,Fujimori H,et al.Radiosensitization effect of poly(ADP-ribose)polymerase inhibition in cells exposed to low and high liner energy transfer radiation[J].Cancer Science,2012,103(6):1045-1050.
32 范雅文,张旭辉,张嵘,等.三阴乳腺癌的异质性及靶向治疗[J].生物技术通讯,2015,26(3):442-445.
33 Heravi M,Kumala S,Rachid Z,et al.ZRBA1,a mixed EGFR/DNA targeting molecule,potentiates radiation response through delayed DNA damage repair process in a triple negative breast cancer model[J].Radiat Oncol Biol Phys,2015,92(2):399-406.
34 Martinel-Lamas DJ,Cortina JE,Ventura C,et al.Enhancement of ionizing radiation response by histamine in vitro and in vivo in human breast cancer[J].Cancer Biol Ther,2015,16(1):137-148.
35 杨芳,管晓翔.MircroRNA在三阴性乳腺癌发生发展中的作用[J].临床肿瘤学杂志,2014,19(10):950-952.
36 Ren YQ,Fu F,Han J.MiR-27a modulates radiosensitivity of triple-negative breast cancer(TNBC)cells by targeting CDC27[J].Med Sci Monit,2015,6(21):1297-1303.

[1]	LI Jiaqi,LUAN Jinwei,ZHANG Yu,LI Xianglan. Analysis of clinicopathological features,recurrence and metastasis in 763 triple-negative breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 244-249.
[2]	LI Shan,ZHAO Chunbo,QIAO Wenbo. Progress in the application of intraoperative radiotherapy in pancreatic cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 280-283.
[3]	FENG Yue,XING Linan,WANG Zhao,ZHANG Yunyan. Correlation between NLR and prognosis of concurrent chemoradiotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 284-288.
[4]	ZHANG Pan, ZHANG Di, DAI Xiaobo. Advanced in re-radiotherapy for recurrent nasopharyngeal carcinoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 92-96.
[5]	DU Yesheng, HU Songliu, XU Xiangying. Study of oligodendrocyte metastasis in non-small cell lung cancer by stereotactic radiotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(2): 154-158.
[6]	SUN Mingliang, XU Jianyu, XU Xiangying. Stereotactic radiotherapy for early stage of non - small cell lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(1): 53-56.
[7]	LIU Guohui, GU Anxin, YIN Hongtao, CAO Yang, HE Yunlong, WANG Chunbo, E Mingyan. Protosappanin A increases the sensitivity of gastric cancer SGC-7901 cells to radiotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(6): 500-505.
[8]	ZHAO Yongrui, XU Jiankun. The application of PET/MRI in high-grade glioma by radiotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(6): 564-568.
[9]	LUO Jianing, HAO Chuncheng, ZHANG Jianxin, LU Jiangyue, GE Xiaofeng. Effect of postoperative adjuvant radiotherapy on prognosis of triple-negative breast cancer patients [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(5): 411-416.
[10]	CHENG Jing,CHEN Ji,WANG Xiaoyong,ZHANG Junhong,ZHOU Fuxiang,XIE Conghua. Changes in the volume of chest muscles and its clinical significance in thoracic radiotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(2): 123-130.
[11]	YU Changyan, ZHEN Lina, LI Hongbing, ZHANG Yue, ZHANG Qingyuan. The correlations between expression of tumor associated macrophages and the prognostic significances in triple negative breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(1): 1-6.
[12]	QU Yuanyuan,XU Xiangying,ZHUANG Ming,YIN Hongtao,HU Songliu,WANG Chunbo,CAO Yang. Nimotuzumab enhances the radiosensitivity of lung cancer A549 cells in vitro [J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(6): 497-501.
[13]	YANG Meijian, BAO Yingna, ZHAO Jianguo. Advances in neoadjuvant therapy of rectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(5): 453-457.
[14]	LIU Wei,LI Huiyan. Progress in relationship between epidermal growth factor receptor and radiosensitivity [J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(3): 275-278.
[15]	DAI Meng, LI Rui, LIU Guiting, LIANG Jinlong, FENG Jinfa, XU Shanyong. The feasibility analysis of breast conserving surgery after neoadjuvant chemotherapy in the treatment with advanced breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(2): 109-113.

The progress of radiotherapy in triple negative breast cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments